Company
In 2012, Masimo acquired Phasein, a developer of capnography and multigas monitoring technologies. Masimo’s vision is to become the partner of choice for those requiring an easy-to-integrate, flexible solution for measuring respiratory gases in a wide range of clinical applications and patient populations. Masimo’s capnography and multigas solutions can provide:
ISA AX+ and ISA OR+ are not licensed for sale in Canada.
For professional use. See instructions for use for full prescribing information including indications, contraindications, warnings and precautions. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
PLCO-005940/PLM-13999A-0622